Rich to the Few

Article
VGIP11 — Patria avalia mega-fundo IPCA+ 5x maior em maio/2026
VGIP11: Patria evaluates consolidating PCIP11, VCJR11, RBRR11 and RPRI11 into an IPCA+ background of R$ 5-7 Bi — five times the size of the CRI Value. Rich Analysis to the Few.
REANÁLISE — Risco competitivo Intermediate ACUMULAR

VGIP11: Patria evaluates mega-fund IPCA+ 5x larger — which changes for those who have unit today

PCIP11, VCJR11, RBRR11 and RPRI11 can create competitor of R$ 5-7 bi. The wallet of VGIP11 does not change — the category board, yes.

I'm a unitholder. I do. VGIP11. . What changes with this consolidation of Patria?

Short answer: nothing on next month's DPS, and probably nothing on next year's DPS. The 49 CRIs of VGIP11 continue to add up, with average 8,44% coupon and duration 3,6 years. April/2026 paid R$ 1,08/unit and the average 12m follows in R$ 0,918/unit. . The consolidation announced by Patria does not touch any of these numbers.

What changes is the competitive board: if the merger of PCIP11 + VCJR11 + RBRR11 + RPRI11 exit, born an IPCA+ fund of R$ 5-7 billion — 5x the size of VGIP11 (R$ 1,08 Bi). For the current unit holder: no reason to sell today with unit to R$ 80,66 and discount of 12% on VP. But it's time to stop treating the VGIP11 as "the average IPCA+ market fund" and start treating it as "the best second option in the category".

R$ 80,66
Quotation (21/05/2026)
Track Feb/26: R$ 76,93 - 83,00
0,88
P/VP
12% discount on VP
R$ 91,635
VP per unit
Heritage R$ 1,08 Bi
R$ 1,08
Dividend apr/2026
Average 12m: R$ 0,918/unit
13,7%
DY cheating 12m
Designed Recurrence: 10,7%
49
Wallet CRIs
99,4% IPCA+ · 0,6% IGP-M
8,44%
Medium Coupon
Duration ZQX0ZX years
100%
Declared liability
49 CRIs without default
84.102
Quotators
Volume R$ 2,6 Mi/day

What Patria's proposing

The movement that enters as a new point in this reanalysis does not come from the portfolio of VGIP11 — comes from competition. Patria assesses consolidating four IPCA+ paper funds that it manages today in a single vehicle: PCIP11 (ex-Polo Capital, now Patria), VCJR11, RBRR11 (ex RBR Capital) and RPRI11.

The fund manager's thesis is direct: today the four funds compete with each other for the same unit portfolio and for the same shelf in the brokers. Each carries its own costs of administration, management, bookkeeping and custody. None of them reach the scale that would give power to negotiate bigger emissions under better conditions. In addition, they arrive at an estimate of R$ 5 at 7 billion of equity.

For quick comparison: o VGIP11 has R$ 1,08 billion. O KNIP11, today the largest pure-IPCA+ fund in the market, is in the home of R$ 3 billions. If the merger breaks out, Patria's new vehicle alone takes the lead of the category — with slack.

Why merge and not leave it as it is?

Four separate FIIs means four administration fees running, four monthly reports, four AGEs, four custody. On scale R$ 1-2 Bi each, the unit cost is high. A single fund of R$ 5-7 Bi has a lower proportional total cost, gains bid in larger primary emissions and occupies space in FII ETFs that today do not carry small assets. For the fund manager: less overhead. For the unit holder: ideally, lower rates and higher liquidity — if the exchange ratio is fair.

What changes in VGIP11 wallet

Nothing. That is the most important point for those who are unit holders today. The consolidation of Patria involves funds from Patria, does not involve Valora. O VGIP11 it follows with the same 49 CRIs, managed by the same team, with the same thesis: 99,4% IPCA+, medium coupon 8,44%, duration 3,6 years.

To reinforce the point, it is worth remembering what Valora did in January/2026: sold R$ 92,5 million in CRIs with IPCA+7% coupon (Tecnisa 397S and San Gonçalo 179E) and purchased R$ 82,1 million in four new CRIs with medium coupon IPCA+9,6% — a spread of almost three percentage points. It was before from the Selic cutting cycle start compressing the curve. It's not management sleeping on point.

In 2025, the rotation of this portfolio generated R$ 22,9 million in capital gains. This is the kind of movement that justifies the management rate — and that the competitor Patria de R$ 5-7 Bi may have difficulty replicating with the same granularity level.

The two competitive scenarios

The risk of consolidation Patria is narrative and structural, not immediate. There are two plausible outcomes and both impact the VGIP11 In different ways.

Scenario A — Approved merger (average probability)

Four-fund unit holders, Patria, accept the exchange relationship. The IPCA+ mega-fund of R$ 5-7 Bi is born. For the VGIP11: It loses competitive advantage of scale. Part of the institutional flow that would seek diversification within the category migrates to the larger vehicle. Bid-ask spread can tighten more on the competitor, harming relatively the VGIP11 in liquidity. It doesn't change the DPS, but it changes the sales narrative in the brokerage companies.

Scenario B — Rejected merger (average probability)

Quotators of at least one of the four funds vote against. FII mergers are not automatic — they need quorum in AGE and depend on acceptance of the exchange relationship. If you lock it, o VGIP11 Wins narrative without doing anything: becomes the second largest pure-IPCA+ alternative on the market, behind only the KNIP11. . Institutional investor who wanted to diversify comes out of small funds Patria and migrates to Valera or Kinea.

In any of the scenarios, the fundamental thesis of VGIP11 It stays intact. What fits is the relative price within the category.

The volatile DPS — do not forget that risk

The consolidation Patria became news, but the main risk of VGIP11 It's still the same as always: the monthly volatility of the DPS because of the IPCA M-2 lag. . The April dividend reflects the IPCA measured in February. The May will reflect the March. And so on.

Month DPS (R$) Remarks
May 2025 1,98 Pico — IPCA scrutinized passed
Aug/2025 0,43 Minimum period
Dec/2025 0,92
Jan/2026 0,64 IPCA M-2 low (nov/25)
Feb/2026 0,73
Mar/2026 0,74
Apr/2026 1,08 Resumption — Stronger Feb/26 IPCA

The moving average of 12 months gives R$ 0,918/unit, and the annual cheating is in R$ 11,02. This is the honest number to design income — not the peak of R$ 1,98 or the minimum of R$ 0,43. Anyone who tries to design a monthly budget with the newly released DPS will miss both ways badly.

There is an extra technical detail that tightens the distribution in months of strong IPCA: the fund pays performance fee of 20% over what exceeds IMA-B5+IPCA. . In months as May/2025 (R$ 1,98), part of the excess stayed with the fund manager. On Feb/2026, the rate was zero.

The strengths that justify holding

Despite the competitive noise, there are concrete reasons for those who are unitholder today not to sell on impulse:

  • P/VP 0,88 over VP of R$ 91,635. R$ 80,66 quote offers 12% security margin. In any scenario in which the real interest curve squeezes minimally, this discount closes — and the capital gained becomes an extra return on the yeld.
  • Average cupom 8,44% with IPCA running the 4,86%. Real cargo higher than the segment average. After the Jan/26 rotation, the average yield on the balance of the portfolio is in 10,19%.
  • 100% default declared in 49 CRIs. Healthy diversification (HHI ~390, 9 distinct real estate segments). No defaults in progress.
  • Pure inflationary hedge. 99,4% IPCA+ — who enters to protect himself from inflation does not need to filter "what part CDI" of the fund.
  • Visible active management. R$ 22,9 million capital gain in 2025 and tactical rotation in Jan/26 before the interest drop cycle. It's not "buy and hold" stagnant.

Those seeking exposure Value without being held hostage by a single curve usually balance with the VGIR11, parallel fund of the same ICD-indexed fund manager — IPCA+ VGIP11, CDI no VGIR11.

The risks that remain on the table

None of this removes the structural points of attention from the fund:

  • Concentration in CRI Campus Matarazzo (~10,7% PL). Construction still under construction. Any delay in marketing or payment noise directly hits the highest position in the portfolio.
  • CRI 84% without international agency rating. Valera monitoring is the only reference. In case of a reputational problem of the fund manager, the investor does not have a second source of assessment.
  • R$ 51 million to recycle in 2026. CRI Choice (R$ 36 Mi wins 04/08/2026) and CRE AR Lands (R$ 15 Mi wins 29/09/2026) add up ~5,4% from PL. Equivalent coupon replacement (~IPCA+9%) in a Selic fall scenario is a real operational challenge.
  • CRI Mabu 402S (8,94% PL). Pulverized hospitality — Cyclical exposure. Warranty 175% mitigates, but execution in hotels is complex.

The three scenarios for the next 12 months

Considering the complete table — intact portfolio, consolidation Open patria, gradually falling Selic cycle:

Base scenario (probability ~55%)

IPCA is anchored in 4,86% (median Focus) and Selic in 14,50% after second consecutive cut. DPS oscillates in the range of R$ 0,70-0,90/month, and the P/VP closes discount in the second semester as the market warrants further interest cuts. Total return 12m: 12-14%.

Optimistic scenario (probability ~25%)

IPCA accelerates to 5%+, Selic stable, management manages to rotate more CRIs to rates higher than IPCA+9%. DPS rises to R$ 0,80-1,00/month and P/VP closes in 1,00 (R$ 91+). Total return above 18% in the year.

Pessimistic scenario (probability ~20%)

Selic falls faster than expected, two CRIs need to renegotiate deadline (Mabu hotelaria, Matarazzo retail) and IPCA slows down to 3,5%. DPS drops to R$ 0,55-0,65/month and P/VP parks in 0,80-0,85. Total return around 9%.

What to monitor in the next 90 days

Four practical triggers to follow:

  1. Call of the AGE of the funds (PCIP11, VCJR11, RBRR11, RPRI11). When it comes out, the proposed exchange relationship gives clues about the real appetite of the unit holders — and of Patria.
  2. Evolution of CRI Campus Matarazzo. . Any payout noise or work schedule directly hits PL 10,7%.
  3. IPCA-15 of the coming months. . Anticipates what enters the DPS via mechanical M-2.
  4. Background cash position (today PL 5,1%). If it falls too much, it signals that management has allocated to new CRIs and can justify passing hard forward.

For who it is and for who it's not

It's for you to: pure inflationary hedge search with IR-free; supports DPS oscillating from R$ 0,55 to R$ 1,50/month without panic; wants to build paper FIIs basket and still has no IPCA+ exposure; believes that the average real market coupon will fall in the next 18 months; has a minimum horizon of 3 years (equal to portfolio duration).

It's not for you to: needs stable DPS month to pay bills; already has 20%+ from the IPCA+ paper portfolio and wants to concentrate more; does not want to follow AGEs and management reports; does not tolerate seeing the unit oscillate 5% in a quarter.

Rich Verdict to the Few: ACUMULAR — note 6,5/10 (vs pairs) · 7,5/10 (absolute)

O VGIP11 delivers a competent portfolio, visible active management and discount of 12% on VP at a time when IPCA+9,6% is a rate that is hardly repeated in primary CRI. For IR-free passive income investor, it's honest purchase below R$ 88.

In the comparative note against the other 14 funds of the medium risk IPCA+ paper category, it is in 6,5 (ACUMULAR) — it is not the best on the shelf, but it is the most consistent. The risk of consolidation Patria does not overturn the current thesis, only recommends moderate weight (15-20% of the FIIs slice at most) and redoubled attention to the forthcoming assembly calls.

Summary in one sentence: o VGIP11 continues to be a good IPCA+ paper fund to R$ 80,66, but whoever buys today needs to know that it is betting on a category that is reorganizing around a five times larger competitor — and that is not necessarily bad.